| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 26F96HRJ3W |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ig epsilon chain C region inhibitor | PubMed |
| Primary Target | |
|---|---|
| immunoglobulin heavy constant epsilon |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 2 | D001249 | ClinicalTrials |
| Urticaria | 2 | D014581 | ClinicalTrials |
| Rhinitis, Allergic, Seasonal | 1 | D006255 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1228538-47-3 |
| ChEMBL | CHEMBL2109456 |
| FDA SRS | 26F96HRJ3W |
| Guide to Pharmacology | 8998 |
CONTENTS